Medical Excellence Capital
Funding rounds backed by Medical Excellence Capital.
- Funding disclosed in full
- $125M
- Median round
- $125M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| SonoThera Develops ultrasound-mediated nonviral genetic medicines | $125MSeries B | BiotechUnited States | 16 participantsAlexandria Venture InvestmentsARCH Venture PartnersARK InvestCureDuchenne VenturesDuquesne Family OfficeIllumina VenturesJohnson & Johnson Innovation – JJDCLeaps by BayerMedical Excellence CapitalOtsuka PharmaceuticalRA CapitalSymBiosisUCB Ventures SAVertex Ventures HCVida VenturesVivo Capital |